Jpmorgan Chase & CO Kronos Bio, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 441 shares of KRON stock, worth $388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
441
Previous 448 1.56%
Holding current value
$388
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$0.82 - $1.07 $5 - $7
-7 Reduced 1.56%
441 $0
Q4 2024

Feb 12, 2025
SELL
$0.82 - $1.07 $3 - $4
-4 Reduced 0.88%
448 $0
Q3 2024

Dec 26, 2024
BUY
$0.92 - $1.5 $93 - $153
102 Added 29.14%
452 $0
Q3 2024

Nov 08, 2024
BUY
$0.92 - $1.5 $93 - $153
102 Added 29.14%
452 $0
Q2 2024

Dec 26, 2024
SELL
$0.73 - $1.38 $74 - $140
-102 Reduced 22.57%
350 $0
Q1 2024

Dec 26, 2024
SELL
$1.02 - $1.3 $104 - $132
-102 Reduced 22.57%
350 $0
Q4 2023

Dec 26, 2024
SELL
$0.75 - $1.49 $76 - $151
-102 Reduced 22.57%
350 $0
Q4 2023

Feb 12, 2024
SELL
$0.75 - $1.49 $878 - $1,744
-1,171 Reduced 76.99%
350 $0
Q3 2023

Nov 14, 2023
SELL
$1.23 - $2.25 $81,729 - $149,505
-66,447 Reduced 97.76%
1,521 $1,000
Q2 2023

Aug 11, 2023
SELL
$1.24 - $1.92 $3.32 Million - $5.13 Million
-2,674,233 Reduced 97.52%
67,968 $116,000
Q1 2023

May 18, 2023
BUY
$1.34 - $2.62 $41,762 - $81,654
31,166 Added 1.15%
2,742,201 $4 Million
Q1 2023

May 11, 2023
BUY
$1.34 - $2.62 $189,533 - $370,580
141,443 Added 5.5%
2,711,035 $3.96 Million
Q4 2022

Feb 13, 2023
BUY
$1.44 - $3.44 $23,040 - $55,040
16,000 Added 0.63%
2,569,592 $4.16 Million
Q3 2022

Nov 14, 2022
SELL
$3.35 - $5.55 $207,452 - $343,689
-61,926 Reduced 2.37%
2,553,592 $8.56 Million
Q2 2022

Aug 11, 2022
BUY
$3.12 - $7.52 $157,469 - $379,541
50,471 Added 1.97%
2,615,518 $9.52 Million
Q1 2022

May 11, 2022
BUY
$6.26 - $14.42 $7.03 Million - $16.2 Million
1,123,528 Added 77.94%
2,565,047 $18.5 Million
Q4 2021

Feb 10, 2022
SELL
$11.35 - $21.18 $524,029 - $977,880
-46,170 Reduced 3.1%
1,441,519 $19.6 Million
Q3 2021

Nov 12, 2021
BUY
$18.17 - $24.7 $27 Million - $36.7 Million
1,487,689 New
1,487,689 $31.2 Million

Others Institutions Holding KRON

# of Institutions
3
Shares Held
887K
Call Options Held
0
Put Options Held
0
View Full List

About Kronos Bio, Inc.

KRON Quotes by TradingView
  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $50M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email